Abbreviations AD: Alzheimers disease ALS: Amyotrophic lateral sclerosis AMPK: Adenosine monophosphate-activated protein kinase A: Amyloid beta peptide A (140) : Amyloid beta peptide comprising amino acids 1 to 40 A (142) : Amyloid beta peptide comprising amino acids 1 to 42 BBB: Bloodbrain barrier BACE-1: Beta-site amyloid precursor protein cleaving enzyme 1 BBR: Berberine BBR-NP: Berberine nanoparticle BBR-NLC: Berberine nanostructured lipid carrier BBR-CTS-NLC: Berberinechitosan nanostructured lipid carrier BBR/PLGA-Tet NPs: Berberinepoly(lactic-co-glycolic acid)/tet-1 peptide nanoparticles BCS: Biopharmaceutical classification system CAT: Catalase ChE: Cholinesterase CNS: Central nervous system COX-2: Cyclooxygenase-2 CREB: cAMP response element-binding protein CUR: Curcumin DNA: Deoxyribonucleic acid GIT: Gastrointestinal tract GSH: Glutathione HD: Huntingtons disease IL-1: Interleukin-1 beta IL-6: Interleukin-6 IL-10: Interleukin-10 LPS: Lipopolysaccharide MAPK: Mitogen-activated protein kinase Mfn1/Mfn2: mitofusin 1 / mitofusin 2 MPTP: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine MWM: Morris water maze ND: Neurodegenerative disease NDs: Neurodegenerative diseases NDDS: Novel drug delivery system NE: Nanoemulsion NFT: Neurofibrillary tangle NF-B: Nuclear factor kappa-light-chain-enhancer of activated B cells NO: Nitric oxide NOS: Nitric oxide synthase NLC: Nanostructured lipid carrier Nrf2: Nuclear factor erythroid 2related factor 2 OPA1: Optic atrophy protein 1 PD: Parkinsons disease Pg-P: P-Glycoprotein PI3K/Akt: Phosphatidylinositol 3-kinase/protein kinase B pathway PLGA: Poly(lactic-co-glycolic acid) PNS: Peripheral nervous system RNA: Ribonucleic acid ROS: Reactive oxygen species SLN: Solid lipid nanoparticle SNEDDS: Self-nanoemulsifying drug delivery system SOD: Superoxide dismutase STZ: Streptozotocin TBARS: Thiobarbituric acid reactive substances TDP-43: Tar DNA-binding protein 43 Tet-1: Targeting peptide tet-1 TNF-: Tumor necrosis factor-alpha TRANS: Transfersome TPGS: D-alpha-tocopheryl polyethylene glycol 1000 succinate Y-Maze: Y-maze test (behavioral assessment) References Islam MR, Rauf A, Rahaman MS, Al-Imran MIK, Fakir MNH, Akter S et al (2025) Clinical and mechanistic exploration of ellagic acid in neurodegenerative diseases: targeted neuroprotection through cellular and molecular mechanisms
Brand products undergo extensive FDA review and quality control
Precautions Maintaining adequate levels of B12 is essential to prevent vitamin B12 deficiency in your body
A half-life for a medication is the time it takes for half of a medication or supplement to be metabolized
& Xia, J
Patch adhesives, preservatives, dyes, and fillers in commercial products can cause contact dermatitis or other reactions
